Literature DB >> 15186905

The problem of evidence-based medicine: directions for social science.

Eric Mykhalovskiy1, Lorna Weir.   

Abstract

Evidence-based medicine (EBM) is arguably the most important contemporary initiative committed to reshaping biomedical reason and practice. The move to establish scientific research as a fundamental ground of medical decision making has met with an enthusiastic reception within academic medicine, but has also generated considerable controversy. EBM and the broader forms of evidence-based decision making it has occasioned raise provocative questions about the relation of scientific knowledge to social action across a variety of domains. Social science inquiry about EBM has not yet reached the scale one might expect, given the breadth and significance of the phenomenon. This paper contributes reflections, critique and analysis aimed at helping to build a more robust social science investigation of EBM. The paper begins with a "diagnostics" of the existing social science literature on EBM, emphasizing the possibilities and limitations of its two central organizing analytic perspectives: political economy and humanism. We further explore emerging trends in the literature including a turn to original empirical investigation and the embrace of "newer" theoretical resources such as postmodern critique. We argue for the need to move the social inquiry of EBM beyond concerns about rationalization and the potential erasure of the patient and, to this end, suggest new avenues of exploration. The latter include analysis of clinical epidemiology and clinical reason as the discursive preconditions of EBM, the role of the patient as a site for the production of evidence, and the textually mediated character of EBM.

Entities:  

Mesh:

Year:  2004        PMID: 15186905     DOI: 10.1016/j.socscimed.2003.12.002

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  30 in total

1.  Hemoglobin A1c as a diagnostic tool: public health implications from an actor-network perspective.

Authors:  Chris Degeling; Melanie Rock
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

2.  Power, technology and social studies of health care: an infrastructural inversion.

Authors:  Casper Bruun Jensen
Journal:  Health Care Anal       Date:  2007-12-18

3.  Defining and Designing Mixed Research Synthesis Studies.

Authors:  Margarete Sandelowski; Corrine I Voils; Julie Barroso
Journal:  Res Sch       Date:  2006

4.  A Troubled Solution: Medical Student Struggles with Evidence and Industry Bias.

Authors:  Kelly Joslin Holloway
Journal:  Sci Eng Ethics       Date:  2014-12-18       Impact factor: 3.525

5.  Public voices in pharmaceutical deliberations: negotiating "clinical benefit" in the FDA's Avastin Hearing.

Authors:  Christa B Teston; S Scott Graham; Raquel Baldwinson; Andria Li; Jessamyn Swift
Journal:  J Med Humanit       Date:  2014-06

6.  Evidence-Based Medicine: A Genealogy of the Dominant Science of Medical Education.

Authors:  Ariane Hanemaayer
Journal:  J Med Humanit       Date:  2016-12

7.  Clinical decision analysis: Incorporating the evidence with patient preferences.

Authors:  Ilyas S Aleem; Hamza Jalal; Idris S Aleem; Adeel A Sheikh; Mohit Bhandari
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

8.  Balancing health care evidence and art to meet clinical needs: policymakers' perspectives.

Authors:  Louise E Parker; Mona J Ritchie; Joann E Kirchner; Richard R Owen
Journal:  J Eval Clin Pract       Date:  2009-12       Impact factor: 2.431

9.  Mapping new theoretical and methodological terrain for knowledge translation: contributions from critical realism and the arts.

Authors:  Pia C Kontos; Blake D Poland
Journal:  Implement Sci       Date:  2009-01-05       Impact factor: 7.327

10.  What is a clinical decision analysis study?

Authors:  Ilyas S Aleem; Emil H Schemitsch; Beate P Hanson
Journal:  Indian J Orthop       Date:  2008-04       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.